
<?xml version='1.0' encoding='UTF-8'?>
<article>
<front>
<journal-meta>
<journal-id journal-id-type='publisher'>IJRAP</journal-id>
<journal-title>International Journal of Research in Ayurveda and Pharmacy</journal-title>
<issn pub-type='ppub'>2277-4343</issn>
 <publisher>
<publisher-name>Moksha Publishing House </publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type='other'>10.7897/2277-4343.1306146</article-id>
<title-group>
<article-title>AYURVEDIC APPROACH FOR MANAGEMENT OF ASRIGDARA: A CASE STUDY
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type='author'>
<name>Neha Malik *</name>
</contrib>
<contrib contrib-type='author'>
<name> Swathi C</name>
</contrib>
<contrib contrib-type='author'>
<name> Ashutosh Chaturvedi </name>
</contrib>
</contrib-group>
<pub-date>
<month>11</month>
<year>-0001</year>
</pub-date>
<fpage>5</fpage>
<lpage>8</lpage>
<abstract><title>Abstract</title>
Introduction: Abnormal uterine bleeding is a broad term that describes irregularities in the menstrual cycle involving frequency, regularity, duration, and flow volume outside pregnancy. The symptoms of Asrigdara, which are expatiated in Ayurveda, are closely similar to that of abnormal uterine bleeding. The approach mode through oral treatment acts as aamapachaka, vatapitta shamaka, agnivardhak, stambhaka, and soolahara. So Ashokarishta, Chandraprabha vati, Avipatikara churna, and Sukumara ghrita were selected to manage the Asrigdara. Method: This is a single case study of a 38-year-old female patient who came with the complaint of increased duration of periods of more than ten days with heavy bleeding and the reduced interval between periods from 2 months. In this case study, palliative management was done with oral Ayurvedic formulations. The main aim of the treatment was to minimize cyclic blood loss with regularization of the cycle and to improve the patient__ampersandsign#39;s general condition. Result: There was a reduction in bleeding and duration of menstrual flow without clots, and the patient remained entirely asymptomatic on observation during follow-ups.
</abstract>
<kwd-group>
<title>Keywords</title>
<kwd>Asrigdara</kwd>
<kwd> Abnormal Uterine Bleeding</kwd>
<kwd> Ayurvedic Treatment Regimen</kwd>
<kwd> Heavy Menstrual Bleeding (HMB)</kwd>
</kwd-group>
<counts><ref-count count='56635'/><page-count count='80'/></counts>
</article-meta></front><back><ref-list><title>References</title></ref-list></back></article>
